Merck (MRK) FCF Margin (QoQ) (2009 - 2026)
Merck (MRK) FCF Margin (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.81 Bn | 633.06 Bn | 17.26 Bn |
| 2 | AbbVie | 469.85 Bn | 463.28 Bn | 12.70 Bn |
| 3 | Merck | 375.13 Bn | 367.99 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.67 Bn | 294.98 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.60 Bn | 252.70 Bn | 12.86 Bn |
| 6 | Amgen | 237.08 Bn | 223.09 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.35 Bn | 180.18 Bn | 6.22 Bn |
| 8 | Pfizer | 160.17 Bn | 148.47 Bn | 10.94 Bn |
| 9 | Gsk | 105.99 Bn | 101.83 Bn | 8.24 Bn |
| 10 | Sanofi | 55.21 Bn | 47.83 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 899.00 |
| Mar 31, 2026 | 685.00 |
| Dec 31, 2025 | -2,844.00 |
| Sep 30, 2025 | 2,356.00 |
| Jun 30, 2025 | 845.00 |
| Mar 31, 2025 | -854.00 |
| Dec 31, 2024 | -3,499.00 |
| Sep 30, 2024 | 2,100.00 |
| Jun 30, 2024 | 1,595.00 |
| Mar 31, 2024 | 1,921.00 |
| Dec 31, 2023 | -4,777.00 |
| Sep 30, 2023 | 2,448.00 |
| Jun 30, 2023 | 1,593.00 |
| Mar 31, 2023 | -2,143.00 |
| Dec 31, 2022 | -620.00 |
| Sep 30, 2022 | 818.00 |
| Jun 30, 2022 | -201.00 |
| Mar 31, 2022 | -499.00 |
| Dec 31, 2021 | 119.00 |
| Sep 30, 2021 | 1,875.00 |